For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 3

Based on the information you provided, we found the following studies.

  • A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial. This clinical research study will collect T cells, a type of white blood cell, through a procedure called leukapheresis.These cells will be used to evaluate cell collection and processing procedures, and learn how these cells could potentially be used in the future to treat a variety of cancers. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) CLL ( Chronic lymphocytic leukemia) Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 2 years old
  • Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and Graft-versus-host Disease in Allogeneic Hematopoietic Cell Transplantation for High-risk Hematologic Malignancies Investigational drug carfilzomib will be added to a standard chemotherapy conditioning regimen for donor blood stem cell transplant to test if this new conditioning regimen can lead to safe and more effective stem cell transplant treatment approach for patients with quickly worsening blood cancers. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) Amyloidosis CLL ( Chronic lymphocytic leukemia) Leukemia Lymphoma MDS ( Myelodysplastic syndrome ) Multiple myeloma Myelofibrosis Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
    • Less than 66 years old
  • A Phase 1/2 Dose Escalation Safety, Pharmacokinetic and Efficacy Study of Multiple IV Administrations of SAR650984 Against CD38 In Patients with Selected CD38+ Hematological Malignancies The main purpose of this study is to evaluate the possible risks and the effectiveness of investigational drug SAR650984 in patients with multiple myeloma. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) CLL ( Chronic lymphocytic leukemia) Multiple myeloma Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old